1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsElevance Health Foundation Behavioral Health Grant is sponsored by Elevance Health Foundation. Supports nonprofit organizations addressing mental health and substance use disorders through treatment, prevention, and social support initiatives.
Get alerted about grants like this
Save a search for “Elevance Health Foundation” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Community Resiliency & Disaster Relief Community Action Leadership Elevance Health Foundation supports the efforts of community-based nonprofit organizations across the country that are improving lives and communities. As a catalyst for positive change, Elevance Health Foundation drives innovative and scalable solutions to address physical, behavioral, and social needs.
Over the next five years, the Foundation will focus our grantmaking efforts on partnerships and programs that can demonstrate measurable and positive change in four key focus areas: Community Resiliency & Disaster Relief The grant application process for each focus area requests specific information related to that area. To respond: Review the overview for your focus area of interest (see below).
Download the request for proposal (RFP) provided. It details the information you will be asked include in the proposal. Access and complete your grant application by using the “Apply” link.
Be sure to note the specific application deadline for your focus area. Maternal/Infant Health. Application deadline: July 31, 2026 Food as Medicine.
Grant applications will be accepted again in 2027 Behavioral Health. Grant applications will be accepted again in 2027 The Foundation will continually update this page to provide current RFP schedules for each focus area. Please check back soon for more information on these deadlines.
(Recognizing that disasters can strike where and when we least expect them, we approach our fourth area of focus, Community Resiliency & Disaster Relief, differently. The Foundation partners with national and local community-based organizations in advance of, during, and after disasters.)
Anchored by our commitment to improving the health of the socially vulnerable, we are prioritizing partnerships and programs that address the physical, behavioral, and social needs of under-resourced communities. Our grant ranges are open; we determine funding levels based on several factors, including the need and the plan presented to address it. Generally, our grants last from one to three years.
The Foundation will prioritize funding for programs that improve maternal/infant health, target disparities, address social needs, and remove barriers to care throughout the pregnancy journey—from pre-conception support to postnatal care for mothers and babies. The programs should drive specific, measurable maternal/infant health outcomes.
Elevance Health Foundation will consider proposals from qualified nonprofit organizations across the U.S. with an emphasis on: National programs. Promoting scalable and sustainable systemic change. Local programs.
Implementing relevant interventions in California, Florida, Georgia, Indiana, Missouri, Nevada, New York, Ohio, Texas, and Virginia. Reducing disparities in pre-term birth rates Reducing disparities in severe maternal morbidity (SMM) incidence Improving maternal/infant health outcomes Download the Maternal/Infant Health RFP Application Deadline: July 31, 2026 Please check back in June for the application.
The Foundation will prioritize funding for programs that improve clinical health outcomes for individuals with diet-related conditions and increase access to nutritious foods for populations experiencing food/nutrition insecurity. Elevance Health will consider proposals from qualified organizations across the U.S. with an emphasis on: National programs. Promoting scalable and sustainable systemic change.
Local programs. Implementing relevant interventions in California, Florida, Georgia, Indiana, Missouri, Nevada, New York, Ohio, Texas, and Virginia.
Improving clinical outcomes for individuals with diet-related conditions experiencing high social risk Increasing access to nutritious foods for populations experiencing high social risk and food/nutrition insecurity Download the Food as Medicine RFP Grant applications will be accepted again in 2027.
The Foundation will prioritize funding for programs that increase the number of individuals receiving treatment for mental health (MH) and/or substance use disorders (SUD), support prevention and early-intervention strategies, and seek to reduce loneliness among individuals with these disorders. Elevance Health will consider proposals from qualified organizations across the U.S. with an emphasis on: National programs.
Promoting scalable and sustainable systemic change. Local programs. Implementing relevant interventions in California, Florida, Georgia, Indiana, Missouri, Nevada, New York, Ohio, Texas, and Virginia.
Achieve a percent increase in the number of individuals receiving treatment services for MH and/or SUD Support prevention and early intervention strategies to reduce risks and harms associated with MH and/or SUD through screenings Reduce feelings of loneliness among individuals with MH and/or SUD Download the Behavioral Health RFP Grant applications will be accepted again in 2027.
Frequently Asked Questions To help you better understand our grantmaking process, we have provided an FAQ sheet with commonly asked questions. Download the FAQs for Grantseekers Item successfully added to your cart Opens an external website Opens an external website in a new window
Based on current listing details, eligibility includes: Nonprofit organizations serving under-resourced, vulnerable, or historically marginalized communities across the U. S. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Varies Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
-Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-007, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funding Opportunity Number: PA-09-006. Assistance Listing: 93.113,93.173,93.361,93.389,93.837,93.846,93.847,93.848,93.849,93.859,93.867. Funding Instrument: G. Category: ED,ENV,FN,HL.
Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of these cancer-relevant nanotechnology applications against the intended cancer type. The proposed projects must be milestone-driven and must be clearly directed toward development of an ultimate commercial product. The outcomes are expected to advance the discovery and pre-clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA) by the end or shortly after completion of the Phase II project period. To facilitate these steps, the NCI will assist the awardees in various ways, including the support through the NCI-sponsored Nanotechnology Characterization Laboratory. This FOA will NOT support basic research projects, studies on disease mechanisms, and clinical trials. Mechanism of Support. This FOA will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Funding Opportunity Number: PAR-10-286. Assistance Listing: 93.393,93.394,93.395,93.396. Funding Instrument: CA. Category: ED,HL. Award Amount: Up to $150K per award.